Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T27442 |
GSK 224876
GSK-224876,GSK224876 |
||
GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI). It has activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects. |